Human Microbiome Market Analysis, Revenue, Price, Market Share, Growth Rate, Forecast To 2028

Human Microbiome Market Global Analysis and Forecast to 2028

Email: sales@theinsightpartners.com

Report Studies

 Human Microbiome Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Device, Drugs and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, and Others) and Application (Therapeutics and Diagnostics) and Geography

2

Email: sales@theinsightpartners.com

Human Microbiome Market Overview  The human microbiome market is expected to reach US$ 2,921.68 million by 2028 from US$ 718.95 million in 2021; it is estimated to grow at a CAGR of 22.2% during 2021–2028.  Technological advancements in metagenomics and next-generation sequencing have made microbiome-based testing easier and cheaper, and they have sped up the process of analysis of the genomic content of microorganisms from human sample. This has bolstered the development process for microbiome-based diagnostics. Gastrointestinal and metabolic disorders accounted for a large share of the diagnostics market in 2018

3

Email: sales@theinsightpartners.com

Key Segment Market

Segment : Human Microbiome Market – by Product, Probiotics ,Foods, Prebiotics,Medical Foods, Diagnostic Devices, Drugs  Human Microbiome Market – by Disease, Obesity, Diabetes,Autoimmune Disorders  Cancer,Mental Disorders  Human Microbiome Market – by Application  Therapeutics  Diagnostics

4

Email: sales@theinsightpartners.com

Human Microbiome Market Value

$50,000

$40,000

$30,000

CAGR of 6.2% $20,000

(2020-2027) $10,000

$0 20XX

Download Sample

20XX

5

Email: sales@theinsightpartners.com

Company Profiles

         

Rebiotix Inc. Yakult Honsha Co., Ltd. Synthetic Biologics Inc. DuPont MaaT Pharma Eligo Bioscience Merck & Co. Inc AOBiome LLC Kaleido Seres Therapeutics

Download Sample Here

6

Email: sales@theinsightpartners.com

By Geography

 North America (the US, Canada, and Mexico)  Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe)  Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific)

 Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa)  South & Central America (Brazil, Argentina, and the Rest of South & Central America).

7

THANK YOU!

Phone : +1-646-491-9876

E-Mail

: sales@theinsightpartners.com

Turn static files into dynamic content formats.

Create a flipbook

Human Microbiome Market Analysis, Revenue, Price, Market Share, Growth Rate, Forecast To 2028

Published on Jul 13, 2022

Shubham Ahire

Market Overview: According to our new research study on “Human Microbiome Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Application, and Disease,” the market is expected to reach US$ 2,921.68 million by 2028 from US$ 718.95 million in 2021; it is estimated to grow at a CAGR of 22.2% during 2021–2028. The report highlights major market drivers and prominent companies along with their key developments in the market. Technological advancements in metagenomics and next-generation sequencing have made microbiome-based testing easier and cheaper, and they have sped up the process of analysis of the genomic content of microorganisms from human sample. This has bolstered the development process for microbiome-based diagnostics. Gastrointestinal and metabolic disorders accounted for a large share of the diagnostics market in 2018 owing to high interest in developing an easy analysis platform for gut health-based disorders, such as irritable bowel syndrome and Crohn’s disease. Metabiomics